Rchr
J-GLOBAL ID：202101011430300550
Update date: Oct. 24, 2024
KAJIWARA Ichie
カジワラ イチエ | KAJIWARA Ichie
Affiliation and department：
Job title：
Research Assistant
Research field (1)：
Anesthesiology
Research theme for competitive and other funds (2)：
- 2024 - 2027 担がんマウスモデルを用いた麻酔薬、鎮痛薬の腫瘍ならびに免疫機構への作用機序の解明
- 2022 - 2024 担がんマウスの心理社会的ストレスと嗅覚障害に対する鎮痛薬の効果
Papers (4)：
-
Tomoaki Itaya, Makoto Sano, Ichie Kajiwara, Yukino Oshima, Tomoya Kuramochi, Jinsuk Kim, Yoshimi Ichimaru, Osamu Kitajima, Atsushi Masamune, Hideaki Ijichi, et al. Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Pain. 2022. 164. 7. 1545-1554
-
Oshima Y, Sano M, Kajiwara I, Ichimaru Y, Itaya T, Kuramochi T, Hayashi E, Kim J, Kitajima O, Masugi Y, et al. Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. British Journal of Anaesthesia. 2022. 128. 4. 679-690
-
KAJIWARA Ichie. Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline pathway and its antitumor effects. PAIN. 2020. 161. 12. 2909-2919
-
Yoshimi Ichimaru, Makoto Sano, Ichie Kajiwara, Takao Tobe, Hiroki Yoshioka, Kazuhiko Hayashi, Hideaki Ijichi, Shinichi Miyairi. Indirubin 3'-Oxime Inhibits Migration, Invasion, and Metastasis InVivo in Mice Bearing Spontaneously Occurring Pancreatic Cancer via Blocking the RAF/ERK, AKT, and SAPK/JNK Pathways. Translational oncology. 2019. 12. 12. 1574-1582
Lectures and oral presentations (9)：
-
The effect of duloxetine on neuronal degeneration of olfactory bulb and olfactory hypersensitivity observed in mice with pancreatic cancer
(2023)
-
MRI(Short TI Inversion Recovery STIR法)による神経ブロック薬液浸潤範囲の評価の試み
(2022)
-
膵癌マウスの嗅球腹側僧帽細胞変性へのデュロキセチンの効果
(2021)
-
デュロキセチンの膵癌自然発症マウスにおける抗腫瘍,抗炎症免疫効果と悪液質予防効果
(2020)
-
心理社会的ストレス軽減による担がんマウスの鎮痛および延命効果
(2020)
ｍore...
Education (3)：
- 2017 - 2021 日本大学 医学部医学研究科外科系麻酔科学
- 2017 - 2021 Nihon University School of Medicine
- 2006 - 2013 日本大学医学部医学科 医学部 医学科
Professional career (1)：
Return to Previous Page
